Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Rituximab as a treatment for factor VIII inhibitor in a patient with chronic GVHD

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Brentjens RJ, Smith L, Reich L, Jakubowski AA . Development of spontaneous factor VIII inhibitor in association with acute graft-versus-host disease. Bone Marrow Transplant 2001; 27: 887–889.

    Article  CAS  Google Scholar 

  2. Seidler CW, Mills LE, Flowers ME, Sullivan KM . Spontaneous factor VIII inhibitor occurring in association with chronic graft-versus-host disease. Am J Hematol 1994; 45: 240–243.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to O S Aljitawi.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wieliczka, M., Ganguly, S., Abhyankar, S. et al. Rituximab as a treatment for factor VIII inhibitor in a patient with chronic GVHD. Bone Marrow Transplant 49, 588 (2014). https://doi.org/10.1038/bmt.2013.229

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2013.229

Search

Quick links